You are here: Industry Insights > CNS

News List

Where Lies the Competitiveness of China's New Drugs for Central Nervous System? Prof. Zhang
October 18, 2024
The Global Challenges and Opportunities of the R&D of New Drugs for Central Nervous System
What is CNS disease? ChatGPT/PharmaSources
November 08, 2023
Central Nervous System (CNS) disease refers to a broad category of medical conditions that affect the brain and spinal cord, which together comprise the central nervous system.
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD) prnasia
February 07, 2022
Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has authorized the company's investigational new drug (IND) application...
WCG Acquires eClinical Provider VeraSci contractpharma
July 27, 2021
WCG has acquired VeraSci, a global provider of specialty scientific expertise and eClinical software to support clinical trials focused on central nervous system (CNS) disorders.
Bioasis Announces the Appointment of Dave Jenkins as CFO firstwordpharma
July 02, 2021
BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the "Company" or "Bioasis") today announced the appointment of Dave Jenkins as Chief Financial Officer.
Cyclolab and EpiPharma Form Joint Venture contractpharma
January 12, 2021
Cyclolab, a cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development company, have signed an agreement to form a joint venture specialty pharmaceutical company to develop ...
Apex Innovative Sciences Supports Three Major COVID-19 Vaccine Trials prnewswire
January 06, 2021
Apex Innovative Sciences (Apex) and its affiliates are proud to announce their participation in three COVID-19 vaccine studies.
Neurana Announces Top-Line Results from Tolperisone Phase 1 CNS Effects Study americanpharmaceuticalreview
December 30, 2020
Neurana Pharmaceuticals announced positive top-line results from the Phase 1 central nervous effects (CNS) clinical study of tolperisone. The study, utilizing a validated driving test, confirmed that tolperisone does not impair driving performance.
Passage Bio Invests in Gene Therapy Manufacturing R&D Site contractpharma
December 18, 2020
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.
Apex Innovative Sciences Pioneers Continuity Strategy in Clinical Site Services During COVID-19 prnewswire
December 03, 2020
Since the emergence of the COVID-19 global pandemic, Apex Innovative Sciences (Apex) has distinguished itself as a leader in clinical trial continuity strategies.

Previous page 1 2 3 Next page